Precigen (PGEN) Net Equity Issued and Repurchased (2012 - 2025)

Precigen (PGEN) has 8 years of Net Equity Issued and Repurchased data on file, last reported at -$355000.0 in Q1 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$355000.0 in Q1 2025; TTM through Dec 2025 was -$355000.0, a 101.14% decrease from a year earlier, with the FY2025 full-year figure at -$355000.0, down 101.14% from the prior year.
• Net Equity Issued and Repurchased for Q1 2025 stood at -$355000.0, up from -$596000.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for PGEN reached as high as $121.0 million in Q1 2021 and fell as low as -$693000.0 in Q2 2023.
• Historically, Net Equity Issued and Repurchased has averaged $37.5 million across 4 years, with a median of $15.7 million in 2024.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 245.84% in 2021 and fell as far as 245.84% in 2021.
• Year by year, Net Equity Issued and Repurchased stood at $121.0 million in 2021, then slumped by 100.57% to -$693000.0 in 2023, then gained by 14.0% to -$596000.0 in 2024, then surged by 40.44% to -$355000.0 in 2025.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were -$355000.0 in Q1 2025, -$596000.0 in Q4 2024, and $31.8 million in Q3 2024.